Carbamazepine Capsule, Extended Release
Product Images NDC 0904-6885

2 FDA label images from Major Pharmaceuticals · Packaging, Regulatory Labels, and Product Appearance

Product Visual Gallery

This gallery contains 2 technical images submitted to the FDA as part of the official labeling for Carbamazepine (NDC 0904-6885). Unlike standard consumer photos, these assets often include clinical data figures, molecular chemical structures, and official manufacturer packaging layouts.

As provided by Major Pharmaceuticals, these visuals offer a comprehensive scientific overview of the product's physical and chemical identity, aiding pharmacists and researchers in product verification and study.

FDA Label Image

Carbamazepine-figure-1 (Carbamazepine Figure 1)

Carbamazepine-figure-1 (Carbamazepine Figure 1)
Chemical structure of the active ingredient carbamazepine, showing its tricyclic dibenzazepine ring system with an amide group attached.*
FDA Label Image

200mg Carton Label (697610a8 E6e7 B0d0 Ef1b 2507d5b73c53 00)

200mg Carton Label (697610a8 E6e7 B0d0 Ef1b 2507d5b73c53 00)
Carbamazepine Extended-Release 200 mg capsules unit dose packaging label by Major Pharmaceuticals. Each unit dose strip contains 30 capsules (3 x 10). Label includes warnings, storage instructions (20°C to 25°C), and a note that the package is not child resistant and intended for institutional use only. Barcode and NDC 0904-6885-04 are also visible.*

* About these descriptions: Image descriptions on this page are generated by automated AI analysis of the product label images from the manufacturer's FDA label submission (SPL). They are provided for reference only and may contain errors or omissions. Always rely on the printed label itself and the official FDA labeling, and consult a pharmacist or healthcare professional with any questions about this product.